LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹32 Cr | ₹32 Cr | ₹34 Cr | ₹43 Cr | ₹41 Cr |
What is the latest Contingent Liabilities ratio of LYKA LABS ?
Year | Contingent Liabilities |
---|---|
Mar2025 | ₹32 Cr |
Mar2024 | ₹32 Cr |
Mar2023 | ₹34 Cr |
Mar2022 | ₹43 Cr |
Mar2021 | ₹41 Cr |
How is Contingent Liabilities of LYKA LABS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹32 Cr | 0.35 | |
Mar2024 | ₹32 Cr | -7.30 | |
Mar2023 | ₹34 Cr | -20.24 | |
Mar2022 | ₹43 Cr | 3.93 | |
Mar2021 | ₹41 Cr | - |
Compare Contingent Liabilities of peers of LYKA LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LYKA LABS | ₹353.6 Cr | -2.2% | -13.1% | -33.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,411.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
LYKA LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LYKA LABS | -2.2% |
-13.1% |
-33.3% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses